TFF peptides and mucins are major components of dacryoliths

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 9, 2006, Pages 1160-1170

  Paulsen, Friedrich P ^a   Schaudig, Ulrich ^b   Fabian, Alexander ^c   Ehrich, Dirk ^a   Sel, Saadettin ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Department of Otorhinolaryngology   (Germany)

Author keywords

Dacryolith; Dacryostenosis; Mucin; Nasolacrimal ducts; Trefoil

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 1; ALPHA DEFENSIN 2; ALPHA DEFENSIN 3; CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; DEFENSIN; GLYCOPROTEIN; MUCIN; MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN 7; MUCIN 8; PEPTIDE; PHOSPHOLIPASE A2; TREFOIL PEPTIDE; TREFOIL PEPTIDE 1; TREFOIL PEPTIDE 2; TREFOIL PEPTIDE 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW KINETICS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LACRIMAL CONCRETION; LACRIMAL DUCT; LACRIMAL DUCT OCCLUSION; LACRIMAL GLAND DISEASE; MACROPHAGE; MALE; MICROSCOPY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STONE ANALYSIS; STONE FORMATION; T LYMPHOCYTE;

ADULT; AGED; CALCULI; DACRYOCYSTORHINOSTOMY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LACRIMAL DUCT OBSTRUCTION; MALE; MIDDLE AGED; MUCINS; NASOLACRIMAL DUCT; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 33747666737     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0167-4     Document Type: Article

References (36)

1. Andreou P, Rose GE (2000) Clinical presentation of patients with dacryolithiasis. Ophthalmology 109:1573-1574
2. Ayub M, Thale A, Hedderich J, Tillmann B, Paulsen F (2003) The cavernous body of the human efferent tear ducts functions in regulation of tear outflow. Invest Ophthalmol Vis Sci. 44:4900-4907
3. Baratz KH, Bartley GB, Campbell RJ, Garrity JA (1991) An eyelash nidus for dacryoliths of the lacrimal excretory and secretory systems. Am J Ophthalmol 111:624-627
4. Berlin AJ, Rath R, Rich L (1980) Lacrimal system dacryoliths. Ophthalmic Surg 11:435-436
5. Duke-Elder S (1952) Textbook of ophthalmology, vol 5: The ocular adnexa. Kimpton, London, p 5364
6. Gonnering RS, Bosniak SL (1989) Recognition and management of acute noninfectious dacryocystic retention. Ophthal Plast Reconstr Surg 5:27-33
7. Hauser F, Poulsom R, Chinery R, Rogers LA, Hanby AM, Wright NA, Hoffmann W (1993) hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 90:6961-6965
8. Hawes MJ (1988) The dacryolithiasis syndrome. Ophthal Plast Reconstr Surg 4:87-90
9. Herzig S, Hurwitz JJ (1979) Lacrimal sac calculi. Can J Ophthalmol 14:17-20
10. Jagla W, Wiede A, Dietzmann K, Rutkowski K, Hoffmann W (2000) Co-localization of TFF3 peptide and oxytocin in the human hypothalamus. FASEB J 14:1126-1131
11. Jones LT (1965) Tear-sac foreign bodies. Am J Ophthalmol 60:111-113
12. Kominek P, Cervenka S, Doskarova S, Heiderova D, Slabik D, Husek P, Busyska J (2002) Dakryolithiasis - analysis of 15 cases. Cesk Slov Oftalmol 58:205-211
13. Lew H, Lee S-Y, Yun Y-S (2004) Measurement of pH, electrolytes and electrophoretic studies of tear proteins in tears of patients with dacryoliths: A novel concept for dacryoliths. Ophthalmologica 218:130-135
14. Linberg JV (2001) Discussion of lacrimal sac dacryoliths. Ophthalmology 108:1312
15. Orhan M, Onerci M, Dayanir V, Orhan D, Irkec T, Irkec M (1996) Lacrimal sac dacryolith: A study with atomic absorption spectrophotometry and scanning electron microscopy. Eur J Ophthalmol 6:478-480
16. Paulsen F, Corfield A, Hinz M, Hoffmann W, Schaudig U, Thale AB, Berry M (2003) Characterization of mucins in human lacrimal sac and nasolacrimal duct. Invest Ophthalmol Vis Sci 44:1807-1813
17. Paulsen F, Hinz M, Schaudig U, Thale AB, Hoffmann W (2002) TFF-Peptides in the human efferent tear ducts. Invest Ophthalmol Vis Sci 43:3359-3364
18. Paulsen F, Langer G, Hoffmann W, Berry M (2004) Human lacrimal gland mucins. Cell Tissue Res 316:167-177
19. Paulsen F, Pufe T, Schaudig U, Held-Feindt J, Lehmann J, Schroder JM, Tillmann BN (2001) Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci 42:2157-2163
20. Paulsen F, Thale A, Hallmann U, Schaudig U, Tillmann B (2000) The cavernous body of the human efferent tear ducts - function in tear outflow mechanism. Invest Ophthalmol Vis Sci 41:965-970
21. Paulsen F, Thale A, Kohla G, Schauer R, Rochels R, Parwaresch R, Tillmann B (1998) Functional anatomy of human duct epithelium. Anat Embryol 198:1-12
22. Paulsen F, Thale A, Maune S, Tillmann B (2001) New insights into the pathophysiology of primary acquired dacryostenosis. Ophthalmology 108:2329-2336
23. Sasaki M, Ikeda H, Ohira S, Ishikawa A, Nakanuma Y (2004) Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis. Peptides 25:763-770
24. Sasaki M, Nakanuma Y, Ho SB, Kim YS (1998) Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis. J Pathol 185:191-198
25. Smith B, Tenzel RR, Buffam FV, Boynton JR (1976) Acute dacryocystic retention. Arch Ophthalmol 94:1903-1904
26. Song KS, Seong JK, Chung KC, Lee WJ, Kim CH, Cho KN, Kang CD, Koo JS, Yoon JH (2003) Induction of MUC8 gene expression by interleukin-1 beta is mediated by a sequential ERK MAPK/RSK1/CREB cascade pathway in human airway epithelial cells. J Biol Chem 278: 34890-34896
27. Thale A, Paulsen F, Rochels R, Tillmann B (1998) Functional anatomy of human efferent tear ducts - a new theory of tear outflow. Graefe's Arch Clin Exp Ophthalmol 236:674-678
28. Thornton DJ, Howard M, Khan N, Sheehan JK (1997) Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule. J Biol Chem 272:9561-9566
29. Tomasetto C, Masson R, Linaires J-L, Wendling C, Lefebvre O, Chenard MP, Rio MC (2000) pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118:70-80
30. Wickström C, Christersson C, Davies JR, Carlstedt I (2000) Macromolecular organization of saliva: Identification of "insoluble" MUC5B assemblies and non-mucin proteins in the gel phase. Biochem J 351:421-428
31. Wickström C, Davies JR, Eriksen GV, Veerman EC, Carlstedt I (1998) MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: Identification of glycoforms and C-terminal cleavage. Biochem J 334:685-693
32. Wiede A, Hinz M, Canzler E, Franke K, Quednow C, Hoffmann W (2001) Synthesis and localization of the mucin-associated TFF peptides in the human uterus. Cell Tissue Res 303:109-115
33. Wiede A, Jagla W, Welte T, Köhnlein T, Busk H, Hoffmann W (1999) Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. Am J Respir Crit Care Med 159:1330-1335
34. Wilkins RB, Pressly JP (1980) Diagnosis and incidence of lacrimal calculi. Ophthal Surg 11:787-789
35. Xing PX, Tjandra JJ, Reynolds K, McLaughlin PJ, Purcell DF, McKenzie IF (1989) Reactivity of anti-human milk fat globule antibodies with synthetic peptides. J Immunol 142:3503-3509
36. Yazici B, Hammad AM, Meyer DR (2001) Lacrimal sac dacryoliths. Predictive factors and clinical characteristics. Ophthalmology 108:1308-1312